Return On Equity in % of Ovid Therapeutics Inc. from Q3 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ovid Therapeutics Inc. quarterly/annual Return On Equity history and change rate from Q3 2017 to Q3 2025.
  • Ovid Therapeutics Inc. Return On Equity for the quarter ending September 30, 2025 was -63.7 %, a 62.4% decline year-over-year.
  • Ovid Therapeutics Inc. annual Return On Equity for 2024 was -33.9 %, a 31.8% increase from 2023.
  • Ovid Therapeutics Inc. annual Return On Equity for 2023 was -49.8 %, a 35.8% decline from 2022.
  • Ovid Therapeutics Inc. annual Return On Equity for 2022 was -36.6 %, a 160% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Ovid Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -63.7 -24.5 -62.4% Jul 1, 2025 Sep 30, 2025
Q2 2025 -58.8 -25.4 -76.1% Apr 1, 2025 Jun 30, 2025
Q1 2025 -34.1 +19.5 +36.4% Jan 1, 2025 Mar 31, 2025
Q4 2024 -33.9 +15.8 +31.8% Oct 1, 2024 Dec 31, 2024
Q3 2024 -39.2 +2.48 +5.94% Jul 1, 2024 Sep 30, 2024
Q2 2024 -33.4 +5.53 +14.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -53.6 -16.1 -42.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -49.8 -13.1 -35.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -41.7 +1.27 +2.95% Jul 1, 2023 Sep 30, 2023
Q2 2023 -38.9 +0.32 +0.82% Apr 1, 2023 Jun 30, 2023
Q1 2023 -37.6 -0.55 -1.49% Jan 1, 2023 Mar 31, 2023
Q4 2022 -36.6 -97.7 -160% Oct 1, 2022 Dec 31, 2022
Q3 2022 -43 -119 -157% Jul 1, 2022 Sep 30, 2022
Q2 2022 -39.2 -130 -143% Apr 1, 2022 Jun 30, 2022
Q1 2022 -37 -165 -129% Jan 1, 2022 Mar 31, 2022
Q4 2021 61.1 +232 Oct 1, 2021 Dec 31, 2021
Q3 2021 75.9 +217 Jul 1, 2021 Sep 30, 2021
Q2 2021 91 +258 Apr 1, 2021 Jun 30, 2021
Q1 2021 128 +264 Jan 1, 2021 Mar 31, 2021
Q4 2020 -171 -52 -43.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -141 -9.46 -7.19% Jul 1, 2020 Sep 30, 2020
Q2 2020 -167 -57.3 -52% Apr 1, 2020 Jun 30, 2020
Q1 2020 -135 -33.9 -33.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -119 -25.6 -27.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -132 -56.4 -75.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -110 -50.2 -83.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -102 -51.5 -103% Jan 1, 2019 Mar 31, 2019
Q4 2018 -93.7 -12.6 -15.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 -75.1 +11 +12.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -60 Apr 1, 2018 Jun 30, 2018
Q1 2018 -50.1 Jan 1, 2018 Mar 31, 2018
Q4 2017 -81.1 Oct 1, 2017 Dec 31, 2017
Q3 2017 -86 Jul 1, 2017 Sep 30, 2017

Ovid Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -33.9 +15.8 +31.8% Jan 1, 2024 Dec 31, 2024
2023 -49.8 -13.1 -35.8% Jan 1, 2023 Dec 31, 2023
2022 -36.6 -97.7 -160% Jan 1, 2022 Dec 31, 2022
2021 61.1 +232 Jan 1, 2021 Dec 31, 2021
2020 -171 -52 -43.6% Jan 1, 2020 Dec 31, 2020
2019 -119 -25.6 -27.3% Jan 1, 2019 Dec 31, 2019
2018 -93.7 -12.6 -15.5% Jan 1, 2018 Dec 31, 2018
2017 -81.1 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.